Abstract
An observational study based on official data (CONACYT and Ministry of Health) was carried out in which the effective reproduction index R(e) and the reproduction index R0 are compared with the mobility presented by Google. Additionally, an overview of the development of the pandemic in Querétaro, Mexico. Highlights key events; such as the main government interventions and social factors that could affect society’s behavior.
A positive relationship is observed between Re, R0, and the levels of mobility presented by Google. This indicates that an increase in mobility is associated with the transmission of SARSCoV-2. In February, a significant decrease in mobility is observed, which lasts until approximately May 1st. This period corresponds to an R0 and R(e) between 1.17 and 1.87. After May 1st, there is a sustained increase in mobility levels. And, as of May 16, the effective reproduction index R (e) and the reproduction index R0 begin to increase. This is expected as it reflects the delay between the infection and the diagnosis of COVID-19. The R0 and R (e) increase from 1.45 on May 16 to 3.59 on July 5. According to the baseline of normal mobility levels, an increase from −49.6% on May 1st, to −20.6% on July 5 was observed.
Based on these data, we conclude that the relaxation of restrictive mobility measures should be reconsidered. Despite this, mobility restrictions must not be a unique mitigation strategy for controlling the Reproductive Index. A comprehensive approach is needed, which generates socio-behavioral changes that allow a further reduction in reproductive rates.
Key Messages
There is a positive correlation between the reproductive number (R0) and the effective reproductive index (Re) of SARS-CoV-2 and mobility trends in Querétaro, Mexico.
A clear increase in mobility in the population in Queretaro, Mexico is associated with an increase in the rate of transmission of Covid-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors report no external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There was no necessary IRB approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The epidemiology data is public, gathered from the Federal Ministry of Health webpage (Direccion General de Epidemiologia. CONACYT, CentroGeo, GeoInt, DataLab. Gobierno Federal Mexico. Updated 15 June 2020. Gathered June 15th, 2020. The mobility data, was gathered from Google's Local Mobility Reports for Queretaro, Mexico.
